vanadates has been researched along with Infarction, Middle Cerebral Artery in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, J; Li, P; Liu, Z; Tang, H; Zhao, D | 1 |
Fukunaga, K; Hamada, J; Hasegawa, Y; Kai, Y; Kawano, T; Morioka, M; Ushio, Y; Yano, S | 1 |
Fukunaga, K; Hasegawa, S; Hasegawa, Y; Kai, Y; Kawano, T; Kuratsu, J; Matsumoto, J; Morioka, M; Yano, S | 1 |
3 other study(ies) available for vanadates and Infarction, Middle Cerebral Artery
Article | Year |
---|---|
Protection by vanadium, a contemporary treatment approach to both diabetes and focal cerebral ischemia in rats.
Topics: Animals; Blood Glucose; Body Weight; Brain; Brain Ischemia; Catalase; Diabetes Mellitus, Experimental; Female; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Infarction, Middle Cerebral Artery; Insulin; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Neuroprotective Agents; Oxidative Stress; Psychomotor Performance; Rats; Rats, Wistar; Survival Rate; Vanadates | 2012 |
Neuroprotective effect of postischemic administration of sodium orthovanadate in rats with transient middle cerebral artery occlusion.
Topics: Animals; Cerebral Cortex; Cerebrovascular Circulation; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Mitogen-Activated Protein Kinases; Neostriatum; Neurons; Neuroprotective Agents; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Regional Blood Flow; Vanadates | 2003 |
Therapeutic time window and dose dependence of neuroprotective effects of sodium orthovanadate following transient middle cerebral artery occlusion in rats.
Topics: Animals; Blood Glucose; Brain Ischemia; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Extracellular Signal-Regulated MAP Kinases; Infarction, Middle Cerebral Artery; Male; Neurons; Neuroprotective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Vanadates | 2006 |